SG Americas Securities’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-574
Closed -$5K 3233
2024
Q1
$5K Sell
574
-761
-57% -$9.08K ﹤0.01% 2905
2023
Q4
$15K Buy
1,335
+182
+16% +$2.03K ﹤0.01% 3022
2023
Q3
$20K Buy
+1,153
New +$42K ﹤0.01% 3045
2023
Q2
Sell
-735
Closed -$50K 3000
2023
Q1
$50K Buy
+735
New +$57.1K ﹤0.01% 3069
2022
Q4
Sell
-532
Closed -$53K 3322
2022
Q3
$53K Buy
+532
New +$62K ﹤0.01% 2984

Other funds holding RBOT

SG Americas Securities's RBOT Position: Q2 2024 in Review

SG Americas Securities sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 574 shares — an estimated $5K sold.

SG Americas Securities first reported a position in RBOT in Q3 2022 and held it in 5 quarters. The position peaked at $53K in Q3 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • SG Americas Securities reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 574 Vicarious Surgical shares in Q2 2024, an estimated $5K.
  • SG Americas Securities first reported a position in Vicarious Surgical in Q3 2022 and held it in 5 quarters.
  • SG Americas Securities's Vicarious Surgical position peaked at $53K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.